Franziska Di Pauli

Franziska Di Pauli

UNVERIFIED PROFILE

Are you Franziska Di Pauli?   Register this Author

Register author
Franziska Di Pauli

Franziska Di Pauli

Publications by authors named "Franziska Di Pauli"

Are you Franziska Di Pauli?   Register this Author

37Publications

763Reads

42Profile Views

Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.

Mult Scler 2020 01 3;26(1):69-78. Epub 2018 Dec 3.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518816614DOI Listing
January 2020

To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosis.

Mult Scler Relat Disord 2019 Dec 23;39:101908. Epub 2019 Dec 23.

Department of Neurology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2019.101908DOI Listing
December 2019

Serum hepcidin levels in multiple sclerosis.

Mult Scler J Exp Transl Clin 2019 Oct-Dec;5(4):2055217319885984. Epub 2019 Nov 4.

Department of Neurology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217319885984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831977PMC
November 2019

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?

Front Immunol 2018 29;9:2753. Epub 2018 Nov 29.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2018.02753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281762PMC
October 2019

Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.

Mult Scler 2019 Mar 21:1352458519838205. Epub 2019 Mar 21.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria/Neuroimaging Research Core Facility, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519838205DOI Listing
March 2019

Change of olfactory function as a marker of inflammatory activity and disability progression in MS.

Mult Scler 2019 02 29;25(2):267-274. Epub 2017 Nov 29.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria/Department of Neurology, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517745724DOI Listing
February 2019

Transient impairment of olfactory threshold in acute multiple sclerosis relapse.

Mult Scler Relat Disord 2018 Jul 26;23:74-77. Epub 2018 May 26.

Department of Neurology, Medical University of Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.05.006DOI Listing
July 2018

Smoking is not associated with higher prevalence of JC virus in MS patients.

Eur J Clin Microbiol Infect Dis 2018 May 8;37(5):907-910. Epub 2018 Feb 8.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10096-018-3204-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916978PMC
May 2018

New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseases.

Mult Scler Relat Disord 2018 May 22;22:35-37. Epub 2018 Feb 22.

Clinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.02.023DOI Listing
May 2018

Dream Content in Patients With Sleep Apnea: A Prospective Sleep Laboratory Study.

J Clin Sleep Med 2018 01 15;14(1):41-46. Epub 2018 Jan 15.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5664/jcsm.6876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734891PMC
January 2018

Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.

Mult Scler 2017 Aug 20;23(9):1241-1248. Epub 2016 Oct 20.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516675751DOI Listing
August 2017

Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.

Mult Scler Relat Disord 2016 Sep 27;9:150-4. Epub 2016 Jul 27.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.07.014DOI Listing
September 2016

Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology.

Neurol Neuroimmunol Neuroinflamm 2015 Dec 4;2(6):e175. Epub 2015 Nov 4.

Clinical Department of Neurology (F.D.P., M.R., R.B., K.S., E.S., T.B.) and Department of Neuroradiology (P.R.), Medical University of Innsbruck; Institute of Neurology (R.H.) and Center for Brain Research (H.L.), Medical University of Vienna, Austria; and Departments of Neurology and Multiple Sclerosis Therapeutics (D.S., K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635550PMC
December 2015

Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.

J Neuroimmunol 2015 Oct 10;287:98-105. Epub 2015 Aug 10.

Clinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; Clinics for Neurological Rehabilitation Münster, Groeben 700, 6232 Münster, Austria; Department of Radiology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2015.08.004DOI Listing
October 2015

Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics.

J Neuroimmunol 2014 Dec 12;277(1-2):145-52. Epub 2014 Oct 12.

Heidelberg University Hospital, Institute for Immunology, Im Neuenheimer Feld 305, 69120 Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.10.001DOI Listing
December 2014

Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.

J Clin Virol 2014 Aug 22;60(4):424-7. Epub 2014 May 22.

Clinical Department of Neurology, Innsbruck Medical University, Anichstr. 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2014.05.007DOI Listing
August 2014

The spectrum of MOG autoantibody-associated demyelinating diseases.

Nat Rev Neurol 2013 Aug 25;9(8):455-61. Epub 2013 Jun 25.

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2013.118DOI Listing
August 2013

Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.

J Neurol Sci 2013 May 21;328(1-2):77-82. Epub 2013 Mar 21.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2013.02.024DOI Listing
May 2013

Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.

Arch Neurol 2012 Jun;69(6):752-6

Division of Pediatric Neurology and Inherited Metabolic Disorders, Department of Pediatrics IV, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneurol.2011.2956DOI Listing
June 2012

Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.

Mult Scler 2012 May 19;18(5):610-5. Epub 2011 Oct 19.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458511426738DOI Listing
May 2012

Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.

Clin Immunol 2011 Mar 18;138(3):247-54. Epub 2010 Dec 18.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2010.11.013DOI Listing
March 2011

Natalizumab treatment reduces endothelial activity in MS patients.

J Neuroimmunol 2010 Oct 23;227(1-2):190-4. Epub 2010 Aug 23.

Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2010.07.012DOI Listing
October 2010

Features of intrathecal immunoglobulins in patients with multiple sclerosis.

J Neurol Sci 2010 Jan 13;288(1-2):147-50. Epub 2009 Oct 13.

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2009.09.016DOI Listing
January 2010